For the readers interested in the stock health of Better Therapeutics Inc. (BTTX). It is currently valued at $1.84. When the transactions were called off in the previous session, Stock hit the highs of $2.00, after setting-off with the price of $1.55. Company’s stock value dipped to $1.50 during the trading on the day. When the trading was stopped its value was $1.49.Recently in News on June 16, 2022, Better Therapeutics to Participate in Cowen 7th Annual FutureHealth Conference. Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that Kevin Appelbaum, Co-Founder and CEO, will participate in the Commercializing Prescription Digital Therapeutics panel at the Cowen 7th Annual FutureHealth Conference on Thursday, June 23, 2022 at 12:40 p.m. ET. You can read further details here
Better Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.1300 on 01/06/22, with the lowest value was $0.9120 for the same time period, recorded on 04/29/22.
Better Therapeutics Inc. (BTTX) full year performance was -81.56%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Better Therapeutics Inc. shares are logging -93.74% during the 52-week period from high price, and 101.75% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.91 and $29.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1627179 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Better Therapeutics Inc. (BTTX) recorded performance in the market was -60.43%, having the revenues showcasing -26.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 47.21M, as it employees total of 44 workers.
Better Therapeutics Inc. (BTTX) in the eye of market guru’s
During the last month, 0 analysts gave the Better Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.2797, with a change in the price was noted -1.84. In a similar fashion, Better Therapeutics Inc. posted a movement of -50.00% for the period of last 100 days, recording 4,264,468 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BTTX is recording 0.35 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.34.
Better Therapeutics Inc. (BTTX): Stocks Technical analysis and Trends
Raw Stochastic average of Better Therapeutics Inc. in the period of last 50 days is set at 40.03%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 45.76%. In the last 20 days, the company’s Stochastic %K was 28.64% and its Stochastic %D was recorded 23.30%.
If we look into the earlier routines of Better Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -60.43%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -60.43%, alongside a downfall of -81.56% for the period of the last 12 months. The shares increased approximately by 32.85% in the 7-day charts and went up by 25.17% in the period of the last 30 days. Common stock shares were lifted by -26.10% during last recorded quarter.